-Tianlong helps Thai hospitals detect hepatitis early with molecular diagnostic solution
XI'AN, China, May 25, 2023 /PRNewswire/ -- Tianlong, an innovative high-tech company specializing in molecular diagnostic products in China, has partnered with public hospitals in northern Thailand to develop screening measures of hepatitis C (HCV) and hepatitis B (HBV), and for the early diagnosis and treatment of the viruses. Globally, more than 350 million people are living with viral hepatitis, and 9 out of 10 people living with hepatitis are unaware of their diagnosis. Tianlong's HCV and HBV detection solution can help reduce disease transmission by enabling early diagnosis and proper treatment.
Since October 2022, Tianlong's HCV and HBV detection solution has been successfully installed in public hospitals in Thailand. The company has reached a 7-year agreement with local hospitals and its solution will be seen in more local hospitals in the future. Compatible with its PANA9600S Nucleic Acid Extractor and Gentier 96 PCR System, Tianlong's HCV and HBV reagents provide a rapid test with high sensitivity, which has received high praise from high-end users.
"Tianlong can provide timely responses both online and offline when we need technical support. We have great confidence in Tianlong's products and would appreciate further cooperation in the future," said a representative from a local hospital in Thailand.
Tianlong's STI solutions will also soon be applied in Thailand to help prevent and control sexually transmitted infections (STIs).
Tianlong is committed to expanding its presence in Thailand and working closely with local partners to provide excellent solutions and services to its customers. The company believes that its molecular diagnostic solutions for hepatitis and other diseases will become increasingly popular in the local market, helping to improve the health and well-being of the local population.
Acerca de Tianlong
Tianlong is an innovative high-tech enterprise specializing in molecular diagnostic products in China. Since its foundation in 1997, Tianlong has been dedicated to providing integrated PCR laboratory solutions for professionals around the world. The company has a wide range of products, ranging from devices to reagents, including nucleic acid extractors, real-time PCR systems, all-in-one molecular diagnostic systems, sample processing systems, liquid handling systems, and 300 types of compatible reagents.
For more information, please visit Tianlong and his LinkedIn, Facebook, and Twitter pages.
For product inquiries or corporate information, please contact inquiry@medtl.com
Photo - https://mma.prnewswire.com/media/2085236...
View original content: https://www.prnewswire.com/news-releases/tianlong-deteccion-en-tailandia-de-hepatitis-con-una-solucion-de-diagnostico-molecular-301835056.html